IGC Pharma, Inc. Earnings Per Share Diluted

• IGC Pharma, Inc. showed an increase of +59.1% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from IGC Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on June 27, 2025.
• XBRL data for this metric is available from 2011 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2011 to 2025), IGC Pharma, Inc.'s Earnings Per Share Diluted has grown by 93.3%.
• Historical annual values: Fiscal year 2025: $0.09 (loss) per share | Fiscal year 2024: $0.22 (loss) per share | Fiscal year 2017: $0.07 (loss) per share | Fiscal year 2016: $0.17 (loss) per share | Fiscal year 2015: $0.31 (loss) per share | Fiscal year 2014: $0.37 (loss) per share | Fiscal year 2013: $0.32 (loss) per share | Fiscal year 2012: $2.66 (loss) per share | Fiscal year 2011: $1.34 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026